Clinical Trials in Tennessee

Showing 2121-2140 of 9,675 trials

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

NCT06213831

This study is being conducted to determine the safety and tolerability of ruxolitinib 1.5% cream under maximal use conditions in participants with Prurigo Nodularis (PN).

Prurigo Nodularis

Incyte Corporation23 participantsStarted Feb 2024

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Fountain Valley, California, United States +17 more locations

Active Not RecruitingNA29 miles

Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

NCT02489539

The purpose of the study is to assess the safety and effectiveness of the GORE® EXCLUDER® Conformable AAA Endoprosthesis to treat an infrarenal aneurysm located in the abdominal aorta. Performance of the GORE® EXCLUDER® Conformable AAA Endoprosthesis will be judged by separate performance goals.

Aortic Aneurysm, Abdominal

W.L.Gore & Associates175 participantsStarted Dec 2017

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +48 more locations

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

Find Trials by Condition in Tennessee

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Expanded Access of Sotorasib

Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis

Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy

Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection

A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.

The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)

A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination With Pembrolizumab or Other Anticancer Treatments in Participants With Advanced Solid Tumors

Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma